(Q37155840)

18 August 2017

Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients (English)

1 reference

18 August 2017

1 reference

3

Suhny Abbara

1 reference

18 August 2017

1

Janice J Hwang

1 reference

18 August 2017

5

Janet Lo

1 reference

18 August 2017

Jeffrey Wei

2

1 reference

PMCID

3766949

18 August 2017

Steven K Grinspoon

series ordinal

4

1 reference

PMCID

3766949

18 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

Journal of Acquired Immune Deficiency Syndromes

18 August 2017

1 reference

18 August 2017

61

1 reference

18 August 2017

3

1 reference

18 August 2017

359-363

1 reference

Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Thematic series on the pathobiology of vascular calcification: an introduction.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766949

A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association

20 October 2018

1 reference

12 December 2020

Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction

1 reference

12 December 2020

Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men

1 reference

12 December 2020

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects

1 reference

12 December 2020

Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes

1 reference

12 December 2020

Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease

1 reference

12 December 2020

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes

1 reference

12 December 2020

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis

1 reference

12 December 2020

Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques

1 reference

12 December 2020

10.1097/QAI.0B013E31826A6C16

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

3766949